FDA Approves Autoinjector Pen for Humira Biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
Medscape Medical News
source https://www.medscape.com/viewarticle/992277?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992277?src=rss
Comments
Post a Comment